Scott Haden Kollins

Scott Haden Kollins

Adjunct Professor in the Department of Psychiatry and Behavioral Sciences

External Address: 
2608 Erwin Road Lakeview Pavi, Durham, NC 27705
Internal Office Address: 
Box 3527 Med Ctr, Durham, NC 27710


Scott H. Kollins, PhD received his undergraduate degree in psychology from Duke and his Master’s and Doctorate degrees in Clinical Psychology from Auburn University. After completing his clinical internship at the University of Mississippi Medical Center, where he served as Chief Intern, he joined the faculty of the Department of Psychology at Western Michigan University for three years, before joining the Duke faculty in 2000. Dr. Kollins has published more than 125 scientific papers in peer-reviewed journals.  Over the past 10 years, his research has been supported by 6 different federal agencies, including NICHD, NIDA, NIMH, NIEHS, NINDS, and EPA, and he currently holds a mid-career K24 award from NIDA.  He has also served as PI on more than 40 industry-funded clinical trials and is a consultant to a number of pharmaceutical companies in the area of ADHD clinical psychopharmacology.  He has served as a standing member of the Child Psychopathology and Developmental Disabilities study section and also served as an ad-hoc reviewer for 10 additional NIH study sections and 7 international granting agencies. He is an Associate Editor for the Journal of Attention Disorders and has reviewed for more than 50 different peer-reviewed journals. He is an elected member of the College on Problems of Drug Dependence and the American College of Neuropsychopharmacology. Dr. Kollins is a licensed clinical psychologist and maintains a practice through the ADHD Program’s outpatient clinic. His research interests are in the areas of psychopharmacology and the intersection of ADHD and substance abuse, particularly cigarette smoking.

Education & Training

  • Ph.D., Auburn University 1997

Mitchell, John T., et al. “How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning.J Atten Disord, vol. 22, no. 9_suppl, July 2018, pp. 49S-60S. Pubmed, doi:10.1177/1087054716685842. Full Text

Dozmorov, Mikhail G., et al. “Associations between maternal cytokine levels during gestation and measures of child cognitive abilities and executive functioning.Brain Behav Immun, vol. 70, May 2018, pp. 390–97. Pubmed, doi:10.1016/j.bbi.2018.03.029. Full Text

Sanchez, C. E., et al. “Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis.Obes Rev, vol. 19, no. 4, Apr. 2018, pp. 464–84. Pubmed, doi:10.1111/obr.12643. Full Text

Lee, Chien-Ti, et al. “Childhood ADHD Symptoms and Future Illicit Drug Use: The Role of Adolescent Cigarette Use.J Pediatr Psychol, vol. 43, no. 2, Mar. 2018, pp. 162–71. Pubmed, doi:10.1093/jpepsy/jsx098. Full Text

Sweitzer, Maggie M., et al. “ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.Neuropsychopharmacology, vol. 43, no. 4, Mar. 2018, pp. 851–58. Pubmed, doi:10.1038/npp.2017.248. Full Text

Schechter, Julia C., et al. “Impact of Smoking Ban on Passive Smoke Exposure in Pregnant Non-Smokers in the Southeastern United States.Int J Environ Res Public Health, vol. 15, no. 1, Jan. 2018. Pubmed, doi:10.3390/ijerph15010083. Full Text

Murphy, Susan K., et al. “Cannabinoid exposure and altered DNA methylation in rat and human sperm.Epigenetics, vol. 13, no. 12, 2018, pp. 1208–21. Pubmed, doi:10.1080/15592294.2018.1554521. Full Text Open Access Copy

Davis, Naomi O., et al. “Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD.Plos One, vol. 13, no. 1, 2018, p. e0189749. Pubmed, doi:10.1371/journal.pone.0189749. Full Text

Mitchell, John T., et al. “A Pilot Trial of Mindfulness Meditation Training for ADHD in Adulthood: Impact on Core Symptoms, Executive Functioning, and Emotion Dysregulation.J Atten Disord, vol. 21, no. 13, Nov. 2017, pp. 1105–20. Pubmed, doi:10.1177/1087054713513328. Full Text

McCullough, Lauren E., et al. “Maternal inflammatory diet and adverse pregnancy outcomes: Circulating cytokines and genomic imprinting as potential regulators?Epigenetics, vol. 12, no. 8, Aug. 2017, pp. 688–97. Pubmed, doi:10.1080/15592294.2017.1347241. Full Text